Paul Vigano Sells 7,000,000 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Paul Vigano sold 7,000,000 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the sale, the insider owned 252,899 shares in the company, valued at approximately $1,578,089.76. The trade was a 96.51% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Trading Up 0.8%

NASDAQ:AVAH opened at $6.68 on Friday. The company’s 50 day moving average price is $6.79 and its 200-day moving average price is $7.72. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.73 and a 52 week high of $10.32. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. The stock has a market cap of $1.45 billion, a price-to-earnings ratio of 5.66, a PEG ratio of 0.75 and a beta of 1.93.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. The firm had revenue of $647.92 million for the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The business’s revenue was up 15.9% on a year-over-year basis. On average, equities research analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.6 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Caitong International Asset Management Co. Ltd raised its position in Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares during the period. Summit Securities Group LLC bought a new position in Aveanna Healthcare in the first quarter worth approximately $53,000. Quantbot Technologies LP bought a new position in Aveanna Healthcare in the second quarter worth approximately $43,000. Lion Street Advisors LLC bought a new position in Aveanna Healthcare in the third quarter worth approximately $89,000. Finally, EverSource Wealth Advisors LLC raised its position in Aveanna Healthcare by 88,100.0% in the third quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company’s stock worth $102,000 after acquiring an additional 11,453 shares during the period. 87.96% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

AVAH has been the topic of a number of research analyst reports. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $10.00 to $11.00 in a research report on Friday, May 15th. Weiss Ratings downgraded shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective on the stock in a research report on Friday, March 20th. Royal Bank Of Canada upgraded shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective on the stock in a research report on Wednesday. Finally, BMO Capital Markets lowered their price objective on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Aveanna Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $10.50.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.